Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patient populatio ...

Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and ...

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growthSYFOVRE® (pegcetacoplan injection) full year 2024 net ...

Routine dental cleanings are essential to keep your teeth and gums clean, remove plaque and tartar build-up, and improve your overall oral health. For your professional dental cleanings, our dental ...

Retinal gene therapy advancements may rewrite the book on treatments for age-related macular degeneration and diabetic eye diseases.

Reducing the number of intravitreal injections to treat age-related macular degeneration (AMD) is a top priority in current ...

The following is a summary of “Cystoid Macular Edema Following Rhegmatogenous Retinal Detachment Repair Surgery: Incidence, ...

Researchers from the NIHR Moorfields Biomedical Research Centre and University College London have found that gene therapy improved visual acuity and preserved retinal structure in young children with ...

Knowing the risk factors of age-related macular degeneration (AMD) and consulting an ophthalmologist or optometrist can help ...

When even the most highly trained surgeons perform procedures on the retina-one of the smallest, most delicate parts of the human body-the stakes are high.